BioNTech SE (NASDAQ: BNTX) files to offer 5 Million ADSs and 750K for selling shareholders.

From the filing:

We are offering 5,000,000 American Depositary Shares, or the ADSs, with each ADS representing one ordinary share, or the Underwritten Offering. The Selling Shareholder identified in this prospectus is offering 750,000 ADSs if and to the extent that the underwriters exercise their option to purchase additional ADSs described below. We will not receive any of the proceeds from the sale of ADS by the Selling Shareholder. The public offering price is $ per ADS. ADSs representing our ordinary shares are listed on the Nasdaq Global Select Market under the symbol “BNTX.” On July 17, 2020, the last reported sale price of the ADSs on the Nasdaq Global Select Market was $85.25 per ADS